Literature DB >> 21914638

Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells.

Xunxian Liu1, Yun-Shang Piao, Julia T Arnold.   

Abstract

Transforming growth factor β1 (TGF-β1) increases dehydro-epiandrosterone (DHEA) metabolism to androgens and prostate-specific antigen (PSA) in a prostate tissue model where stromal (6S) cells and epithelial (LAPC-4) cells are cocultured. Red clover (RC) isoflavones inhibits transforming growth factor (TGF)-β-induced androgenicity. Mechanisms controlling those activities were explored. Three hydroxysteroid dehydrogenases (HSDs), 3β-HSD, HSD-17β1 and HSD-17β5 involved in metabolizing DHEA to testosterone (TESTO) were investigated. Individual depletion of HSDs in 6S cells significantly reduced TGF-β1/DHEA-induced PSA in LAPC-4 cells in cocultures. Monomer amounts of 3β-HSD were similar without or with TGF-β1 in both cell types but aggregates of 3β-HSD in 6S cells were much higher than those in LAPC-4 cells and were upregulated by TGFβ in 6S cells. Basal and TGF-β1-treated levels of HSD-17β1 and HSD-17β5 in LAPC-4 cells were significantly lower than in 6S cells, whereas levels of HSD-17β1 but not HSD-17β5 were TGFβ inducible. 6S cell HSD genes expression induced by TGFβ or androgen signaling was insignificant to contribute TGF-β1/DHEA-upregulated protein levels of HSDs. RC decreased TGF-β1- upregulation of aggregates of 3β-HSD but not HSD-17β1. Depletion of TGFβ receptors (TGFβ Rs) reduced TGF-β1/DHEA-upregulated HSDs and TESTO. Immunoprecipitation studies demonstrated that TGF-β1 disrupted associations of TGFβ Rs/HSDs aggregates, whereas RC suppressed the dissociations of aggregates of 3β-HSD but not HSD-17β1 from the receptors. Given that TGFβ Rs are recycled with or without ligand, TGF-β1-induced disassociation of the HSDs from TGFβ Rs may increase stability and activity of the HSDs. These data suggest a pathway connecting overproduction of TGFβ with increased PSA in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914638      PMCID: PMC3218644          DOI: 10.1093/carcin/bgr206

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  27 in total

1.  Rational basis for Trk inhibition therapy for prostate cancer.

Authors:  A T Weeraratna; J T Arnold; D J George; A DeMarzo; J T Isaacs
Journal:  Prostate       Date:  2000-10-01       Impact factor: 4.104

2.  Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.

Authors:  Xunxian Liu; Renee Y Choi; Shayma M Jawad; Julia T Arnold
Journal:  Prostate       Date:  2010-10-28       Impact factor: 4.104

Review 3.  Reactive stroma in prostate cancer progression.

Authors:  J A Tuxhorn; G E Ayala; D R Rowley
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

Review 4.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

5.  Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.

Authors:  D M Peehl; R G Sellers
Journal:  Exp Cell Res       Date:  1997-05-01       Impact factor: 3.905

6.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.

Authors:  Jennifer A Tuxhorn; Gustavo E Ayala; Megan J Smith; Vincent C Smith; Truong D Dang; David R Rowley
Journal:  Clin Cancer Res       Date:  2002-09       Impact factor: 12.531

Review 7.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

8.  Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells.

Authors:  G Carruba; O M Granata; R Farruggio; S Cannella; A L Bue; R E Leake; M Pavone-Macaluso; L A Castagnetta
Journal:  Steroids       Date:  1996-01       Impact factor: 2.668

9.  Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11.

Authors:  Hugh Mitchell; Amit Choudhury; Richard E Pagano; Edward B Leof
Journal:  Mol Biol Cell       Date:  2004-06-30       Impact factor: 4.138

Review 10.  Dehydroepiandrosterone (DHEA)--the "mother steroid". I. Immunologic action.

Authors:  W Regelson; R Loria; M Kalimi
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

View more
  3 in total

1.  Intraurethral injection with LPS: an effective experimental model of prostatic inflammation.

Authors:  Fabiana Oliveira Dos Santos Gomes; Amanda Costa Oliveira; Edlene Lima Ribeiro; Bruna Santos da Silva; Laise Aline Martins Dos Santos; Ingrid Tavares de Lima; Amanda Karolina Soares E Silva; Shyrlene Meiry da Rocha Araújo; Terezinha Gonçalves; Mario Ribeiro de Melo-Junior; Christina Alves Peixoto
Journal:  Inflamm Res       Date:  2017-11-18       Impact factor: 4.575

2.  Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.

Authors:  Fen Jin; Chunpeng Wan; Weifang Li; Liangliang Yao; Hongqian Zhao; Yuan Zou; Dewei Peng; Weifeng Huang
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

Review 3.  Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.

Authors:  Chen-Ming Zeng; Lin-Lin Chang; Mei-Dan Ying; Ji Cao; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Front Pharmacol       Date:  2017-03-14       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.